Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 541 AL 555

Hereditary diffuse leukoencephalopathy with spheroids - a volumetric and radiological comparison with multiple sclerosis patients and healthy controls

Granberg T, Hashim F, Andersen O, Sundal C, Karrenbauer VD.

Eur J Neurol. 2016 Apr;23(4):817-22. doi: 10.1111/ene.12948. Epub 2016 Jan 12.

Systematic Review of the Relationship between Vitamin D and Parkinson's Disease

Rimmelzwaan LM, van Schoor NM, Lips P, Berendse HW, Eekhoff EM.

J Parkinsons Dis. 2016;6(1):29-37. doi: 10.3233/JPD-150615.

Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures

Ye Z, Rae CL, Nombela C, Ham T, Rittman T, Jones PS, Rodríguez PV, Coyle-Gilchrist I, Regenthal R, Altena E, Housden CR, Maxwell H, Sahakian BJ, Barker RA, Robbins TW, Rowe JB.

Hum Brain Mapp. 2016 Mar;37(3):1026-37. doi: 10.1002/hbm.23087. Epub 2016 Jan 12.

Bumetanide to Treat Parkinson Disease: A Report of 4 Cases

Damier P, Hammond C, Ben-Ari Y.

Clin Neuropharmacol. 2016 Jan-Feb;39(1):57-9. doi: 10.1097/WNF.0000000000000114.

Parkinsonism in Patients With Chronic Hepatitis C Treated With Interferons: Case Reports and Review of the Literature

Wangensteen KJ, Krawitt EL, Hamill RW, Boyd JT.

Clin Neuropharmacol. 2016 Jan-Feb;39(1):1-5. doi: 10.1097/WNF.0000000000000120.

A Case of Parkinson Disease With Both Visual Hallucination and Pain Improved by Gabapentin

Abe K, Chiba Y, Katsuse O, Hirayasu Y.

Clin Neuropharmacol. 2016 Jan-Feb;39(1):55-6. doi: 10.1097/WNF.0000000000000122.

Investigational drugs for autonomic dysfunction in Parkinson's disease

Perez-Lloret S.

Expert Opin Investig Drugs. 2016;25(3):259-62. doi: 10.1517/13543784.2016.1135128. Epub 2016 Jan 12.

The Importance of Thrombin in Cerebral Injury and Disease

Krenzlin H, Lorenz V, Danckwardt S, Kempski O, Alessandri B.

Int J Mol Sci. 2016 Jan 11;17(1):84. doi: 10.3390/ijms17010084.

Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis

Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A, Logroscino G.

Neurology. 2016 Feb 9;86(6):566-76. doi: 10.1212/WNL.0000000000002350. Epub 2016 Jan 13.

Prospective study of plasma urate and risk of Parkinson disease in men and women

Gao X, O'Reilly ÉJ, Schwarzschild MA, Ascherio A.

Neurology. 2016 Feb 9;86(6):520-6. doi: 10.1212/WNL.0000000000002351. Epub 2016 Jan 13.

Increased Risk of Parkinson's Disease in Patients With Obstructive Sleep Apnea: A Population-Based, Propensity Score-Matched, Longitudinal Follow-Up Study

Yeh NC, Tien KJ, Yang CM, Wang JJ, Weng SF.

Medicine (Baltimore). 2016 Jan;95(2):e2293. doi: 10.1097/MD.0000000000002293.

Insights into Mechanisms of Chronic Neurodegeneration

Diack AB, Alibhai JD, Barron R, Bradford B, Piccardo P, Manson JC.

Int J Mol Sci. 2016 Jan 12;17(1):82. doi: 10.3390/ijms17010082.

A Review of the Association Between Parkinson Disease and Malignant Melanoma

Disse M, Reich H, Lee PK, Schram SS.

Dermatol Surg. 2016 Feb;42(2):141-6. doi: 10.1097/DSS.0000000000000591.

Telomere length in Parkinson's disease: A meta-analysis

Forero DA, González-Giraldo Y, López-Quintero C, Castro-Vega LJ, Barreto GE, Perry G.

Exp Gerontol. 2016 Mar;75:53-5. doi: 10.1016/j.exger.2016.01.002. Epub 2016 Jan 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias